Literature DB >> 28979803

BANCR: a cancer-related long non-coding RNA.

Xin Yu1, Heyi Zheng1, Matthew Tv Chan2, William Ka Kei Wu2,3.   

Abstract

Long non-coding RNAs (lncRNAs) are a group of non-protein-coding RNAs with more than 200 nucleotides in length. lncRNAs are involved in diverse biological processes, including development, cell proliferation and differentiation. Emerging evidences also suggest that lncRNAs may participate in cancer development by functioning as tumor suppressors and oncogenes. BRAF-activated non-coding RNA (BANCR) was first identified as an oncogene in melanoma. Later studies demonstrated that BANCR was frequently deregulated in human cancers, including lung cancer, gastric cancer, colorectal cancer, thyroid cancer and osteosarcoma. Nevertheless, the direction of deregulation was tissue-specific in which BANCR could as an oncogene or tumor-suppressor gene. In this review, we compile current evidences concerning the functional roles and molecular mechanisms of BANCR in tumor development.

Entities:  

Keywords:  BANCR; Long non-coding RNAs; cancer; oncogene

Year:  2017        PMID: 28979803      PMCID: PMC5622215     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  83 in total

1.  Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer.

Authors:  Ling Li; Lei Zhang; Yan Zhang; Fang Zhou
Journal:  Biomed Pharmacother       Date:  2015-04-14       Impact factor: 6.529

Review 2.  MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.

Authors:  Xin Yu; Zheng Li; Jun Yu; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-07-22       Impact factor: 6.831

3.  HER2/ERBB2 immunoreactivity in human retinoblastoma.

Authors:  G M Seigel; S Sharma; A S Hackam; Dhaval K Shah
Journal:  Tumour Biol       Date:  2015-11-27

4.  Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival.

Authors:  Yan Nie; Xiang Liu; Shaohua Qu; Erwei Song; Hua Zou; Chang Gong
Journal:  Cancer Sci       Date:  2013-01-30       Impact factor: 6.716

5.  MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.

Authors:  Y Xu; F Zhao; Z Wang; Y Song; Y Luo; X Zhang; L Jiang; Z Sun; Z Miao; H Xu
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

6.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.

Authors:  Kornelius Schulze; Sandrine Imbeaud; Eric Letouzé; Ludmil B Alexandrov; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Clément Meiller; Jayendra Shinde; Frederic Soysouvanh; Anna-Line Calatayud; Roser Pinyol; Laura Pelletier; Charles Balabaud; Alexis Laurent; Jean-Frederic Blanc; Vincenzo Mazzaferro; Fabien Calvo; Augusto Villanueva; Jean-Charles Nault; Paulette Bioulac-Sage; Michael R Stratton; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Nat Genet       Date:  2015-03-30       Impact factor: 38.330

7.  Correction: Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation.

Authors: 
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

8.  Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways.

Authors:  Ymera Pignochino; Giovanni Grignani; Giuliana Cavalloni; Manuela Motta; Marta Tapparo; Stefania Bruno; Alessia Bottos; Loretta Gammaitoni; Giorgia Migliardi; Giovanni Camussi; Marco Alberghini; Bruno Torchio; Stefano Ferrari; Federico Bussolino; Franca Fagioli; Piero Picci; Massimo Aglietta
Journal:  Mol Cancer       Date:  2009-12-10       Impact factor: 27.401

9.  Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer.

Authors:  Zhi-Yuan Xu; Qi-Ming Yu; Yi-An Du; Li-Tao Yang; Rui-Zeng Dong; Ling Huang; Peng-Fei Yu; Xiang-Dong Cheng
Journal:  Int J Biol Sci       Date:  2013-06-28       Impact factor: 6.580

10.  BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.

Authors:  Haitao Zheng; Meng Wang; Lixin Jiang; Haidi Chu; Jinchen Hu; Jinyao Ning; Baoyuan Li; Dong Wang; Jie Xu
Journal:  Cancer Res Treat       Date:  2015-08-12       Impact factor: 4.679

View more
  17 in total

Review 1.  CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma.

Authors:  Xin Yu; Heyi Zheng; Gary Tse; Lin Zhang; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2018-08-09       Impact factor: 6.831

2.  A novel 7‑hypoxia‑related long non‑coding RNA signature associated with prognosis and proliferation in melanoma.

Authors:  Yi Luo; Tinghao Li; Hengguang Zhao; Aijun Chen
Journal:  Mol Med Rep       Date:  2022-06-15       Impact factor: 3.423

3.  Extracellular Vesicles-Encapsulated miR-153-3p Potentiate the Survival and Invasion of Lung Adenocarcinoma.

Authors:  Hongli Cao; Ping Zhang; Hong Yu; Jianing Xi
Journal:  Mol Cells       Date:  2022-06-30       Impact factor: 4.250

Review 4.  Long non-coding RNAs: crucial regulators of gastrointestinal cancer cell proliferation.

Authors:  Jiaxin Chen; Shuiping Liu; Xiaotong Hu
Journal:  Cell Death Discov       Date:  2018-04-27

5.  lncRNA FBXL19-AS1 regulates osteosarcoma cell proliferation, migration and invasion by sponging miR-346.

Authors:  Runsang Pan; Zhixu He; Wanyuan Ruan; Sun Li; Hui Chen; Zhiyu Chen; Fang Liu; Xiaobin Tian; Yingjie Nie
Journal:  Onco Targets Ther       Date:  2018-11-29       Impact factor: 4.147

6.  Long noncoding RNA DNAJC3-AS1 promotes osteosarcoma progression via its sense-cognate gene DNAJC3.

Authors:  Ridong Liang; Zezheng Liu; Zhixu Chen; Yang Yang; Yuejun Li; Zhifei Cui; Ajuan Chen; Zhenxue Long; Jinbin Chen; Jiachun Lu; Bin Huang; Qingchu Li
Journal:  Cancer Med       Date:  2019-01-16       Impact factor: 4.452

7.  LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.

Authors:  Xinquan Wu; Tianfang Xia; Meng Cao; Pengbo Zhang; Guodong Shi; Lei Chen; Jingjing Zhang; Jie Yin; Pengfei Wu; Baobao Cai; Zipeng Lu; Yi Miao; Kuirong Jiang
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

Review 8.  Cascades between miRNAs, lncRNAs and the NF-κB signaling pathway in gastric cancer (Review).

Authors:  Risheng Chen; Mingxiu Yang; Weiguo Huang; Baiyun Wang
Journal:  Exp Ther Med       Date:  2021-05-17       Impact factor: 2.447

9.  LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer.

Authors:  Siping Ma; Dongxiang Yang; Yanlong Liu; Yongpeng Wang; Tao Lin; Yanxi Li; Shihua Yang; Wanchuan Zhang; Rui Zhang
Journal:  Aging (Albany NY)       Date:  2018-08-22       Impact factor: 5.682

10.  Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.

Authors:  Sheng Xue; Sheng-Qun Jiang; Qing-Wen Li; Sheng Wang; Jian Li; Shuai Yang; Hai-Min Zhang; Yun-Fei Xu; Long-Sheng Wang; Jun-Hua Zheng
Journal:  BMC Urol       Date:  2018-09-10       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.